Evaluation of Hepatic Encephalopathy Triggers and Outcomes in Chronic Liver Disease: A Regional Perspective
DOI:
https://doi.org/10.36283/ziun-pjmd14-2/002Keywords:
Hepatic Encephalopathy, Liver Cirrhosis, Liver Diseases, Gastrointestinal Hemorrhage, End Stage Liver DiseaseAbstract
Background: Chronic liver disease (CLD) accounts for a neuropsychiatric complication called hepatic encephalopathy (HE). This study aimed to explore the key precipitating factors in HE and determine how they correlated with disease severity; findings were compared to global trends.
Methods: This cross-sectional study was carried out (December 2019 to July 2020) at the Asian Institute of Medical Sciences (AIMS), Hyderabad, Pakistan. A total of 205 patients with secondary HE to CLD were included. Using the consecutive techniques, demographic characteristics, precipitating factors, used liver dysfunction scores (Child-Turcotte-Pugh and Model for End-Stage Liver Disease) were analysed using SPSS version 20. significant associations (p < 0.05) were identified statistically using Chi-square and ANOVA test.
Results: Electrolyte imbalances (48%) (n=98), principally hyponatremia (18%) (n=37), were the most frequent precipitating factors, while the most common precipitating factors were infections (35.1%) (n=72) with spontaneous bacterial peritonitis being the most frequent (16.6%) (n=34). In 14.6% (n=30) of cases, gastrointestinal bleeding was observed. Infected and severe electrolyte disturbance (p<0.05) were significantly associated with higher grades of HE (Grade III/IV). Patients with Child C classification and MELD >20 had a more severe history of HE episodes. Infections were more common in older patients (≥60 years), whereas younger patients (<40 years) were more susceptible to dehydration and development of gastrointestinal bleeding.
Conclusion: Electrolyte imbalances and infections were the main precipitants. Electrolyte monitoring, infection control, and demographics-specific strategies are paramount to improving patient outcomes.
References
Heusinger D, Dhiman RK, Felipa V, Garg B, Jalan R, Kirsches G et al. Hepatic encephalopathy. Nature Reviews Disease Primers. 2022 Jun;8(1):43. Doi: 10.1038/s41572-022-00366-6
Glairing SJ, Mangini C, Antonello L, Gioia S, Nielsen EJ, Danneberg S et al. Prevalence of minimal hepatic encephalopathy in patients with liver cirrhosis: A multicenter study. Official journal of the American College of Gastroenterology| ACG. 2022 Mar:10-4309. Doi: 10.14309/ajg.0000000000002251
Tejpal S, Sharma SK, Sharma A, Sharma S. A comprehensive review on hepatic encephalopathy: pathophysiology, symptoms, epidemiology, classification, diagnosis and treatment. J Res Appl Sci Biotechnology. 2024 Jun;3(3):170-80. doi:10.55544/jrasb.3.3.27
Nardelli S, Riggio O, Gioia S, Merli M, Spagnoli A, di Martino M et al. Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts. Digestive and Liver Disease. 2022 Aug;54(8):1060-5. Doi: 10.1016/j.dld.2021.12.015
Bhattarai S, Karki D. Clinical profile, precipitating factors and outcome of hepatic encephalopathy in patients with liver cirrhosis. Med Phoenix. 2021 Jul;6(1):23-7. doi:10.3126/medphoenix.v6i1.36796
Singh HM, Sharma LR, Bijoy M. Precipitating Factors and Outcome of Hepatic Encephalopathy-A Hospital Base Cross Sectional Study. Int J Accad Med Pharm. 2023 Aug;5(5):1808-15. Doi: 10.47009/jamp.2023.5.5.356
Razai A, Safi IK, Saidi SA, Saidi SI. Prevalence of Precipitating Factors of Hepatic Encephalopathy at Nangarhar Regional Hospital. Nangarhar University International Journal of Biosciences. 2023 Sep;2(03):34-41. doi:10.70436/nuijb.v2i03.67
Xu X, Yang Y, Tan X, Zhang Z, Wang B, Yang X et al. Hepatic encephalopathy post-TIPS: current status and prospects in predictive assessment. Computational and Structural Biotechnology Journal. 2024 Jul; 24:493-506. Doi: 10.1016/j.csbj.2024.07.008
Ravindranath A, Srivastava A, Yacht SK, Poddar U, Sarma MS, Mathias A. Prevalence and Precipitants of Hepatic Encephalopathy in Hospitalized Children with Chronic Liver Disease. Journal of Clinical and Experimental Hepatology. 2024 Nov;14(6):101452. Doi: 10.1016/j.jceh.2024.101452
Waseem T, Latif SL, Chaudhary UC, Hanif FH. Effectiveness Of Oral Glutamine Challenge Test in Diagnosing Minimal Hepatic Encephalopathy in Liver Cirrhosis Patients. Journal of Akhtar Saeed Medical & Dental College. 2021 Jan;3(01). doi:10.1155/2013/547670
García-Martínez R, Diaz-Ruiz R, Ponceau M. Management of hepatic encephalopathy associated with advanced liver disease. Clinical Drug Investigation. 2022 Jun;42(Suppl 1):5-13. Doi: 10.1007/s40261-022-01146-6
Rehman S, Fatima QU, Rehman S, Sami Z, Ali H, Sadiqi I. Comparison of current and emerging strategies for treating hepatic encephalopathy. The Professional Medical Journal. 2021 Nov;28(12):1705-10. doi:10.29309/tam/2021.28.12.6644
Long L, Li H, Deng G, Wang X, Lu S, Li B et al. Impact of hepatic encephalopathy on clinical characteristics and adverse outcomes in prospective and multicenter cohorts of patients with acute-on-chronic liver diseases. Frontiers in Medicine. 2021 Aug; 8:709884. Doi: 10.3389/fmed.2021.709884
Duah A, Nkansah AA, Okine R, Duah F. Prevalence and Precipitating Factors of Hepatic Encephalopathy in Patients with Liver Cirrhosis and Ascites Admitted at Korle Bu Teaching Hospital in Ghana. Postgraduate Medical Journal of Ghana. 2021 Jul;10(1):31-6. doi:10.60014/pmjg.v10i1.248
Lim CG, Lee HJ. Pattern Clustering of Symmetric Regional Cerebral Edema on Brain MRI in Patients with Hepatic Encephalopathy. Journal of the Korean Society of Radiology. 2024 Mar;85(2):381. Doi: 10.3348/jksr.2023.0012
Belafonte D, Gioia S, Facciolo J, Riggio O, Radula L, Nardelli S. Old and new precipitants in hepatic encephalopathy: A new look at a field in continuous evolution. Journal of Clinical Medicine. 2023 Feb;12(3):1187.doi: 10.3390/jcm12031187
Zhu L, Zhang W, Chen L, Ren Y, Cao Y, Sun T et al. Brain gray matter alterations in hepatic encephalopathy: A voxel-based meta-analysis of whole-brain studies. Frontiers in human neuroscience. 2022 Apr; 16:838666. Doi: 10.3389/fnhum.2022.838666
Khan MS, Khan FU, Sohail M, Fahim M, Akhter S, Shahid M et al. Frequency of Upper Gastrointestinal Bleeding as Precipitant of Hepatic Encephalopathy among Patients with Liver Cirrhosis. Pakistan Journal of Medical & Health Sciences. 2022 Oct;16(08): 710-.doi:10.53350/pjmhs22168710
Triantafyllou K, Kolackies P, Gralen IM, Oakland K, Manes G, Radaelli F et al. Diagnosis and management of acute lower gastrointestinal bleeding: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy. 2021 Aug;53(08):850-68. Doi: 10.1055/a-1496-8969
Khobragade H, Manohar T, Athawale A. Precipitating Factors and Clinic-Endoscopic Study of Patients with Hepatic Encephalopathy Type C. Journal of Contemporary Medicine. 2022 Jul;12(4):559-64. doi:10.61919/jhrr.v4i1.443
Sohail R, Hassan IH, Rukh M, Saqib M, Iftikhar M, Mumtaz H. Assessing Thrombocytopenia and Chronic Liver Disease in Southeast Asia: A Multicentric Cross-Sectional Study. Cures. 2023 Aug;15(8). Doi: 10.7759/cureus.43356
Jamal Inia M, Lonardo A, Neunkirchen R. Sex and gender differences in liver fibrosis: path mechanisms and clinical outcomes. Fibrosis. 2024 Oct;2(4):10006. doi:10.70322/fibrosis.2024.10006
Tapper EB, Saleh ZM, Nikirk S, Bajaj J, Chen X, Lok AS. Medically Tailored Meals for Patients with Cirrhosis and Hepatic Encephalopathy: The BRAINFOOD Proof-of-concept Trial. Journal of Clinical and Experimental Hepatology. 2024 Nov;14(6):101439. Doi: 10.1016/j.jceh.2024.101439
Huang DQ, Perrault NA, Tacke F, Gluud LL, Arrese M, Buginese E et al. Global epidemiology of cirrhosis—aetiology, trends and predictions. Nature reviews Gastroenterology & hepatology. 2023 Jun;20(6):388-98. Doi: 10.1038/s41575-023-00759-2
Montagnese S, Raito PE, Romero-Gómez M, Larsen FS, Shawcross DL, Thabit D et al. EASL Clinical Practice Guidelines on the management of hepatic encephalopathy. Journal of hepatology. 2022 Sep;77(3):807-24. Doi: 10.1016/j.jhep.2022.06.001
Thabit D, Bouzid C, Meunier L, Haas M, Weiss N, Louvet A et al. Diagnosis and management of hepatic encephalopathy: The French recommendations. Liver International. 2023 Apr;43(4):750-62. Doi: 10.1111/liv.15510
Nardelli S, Gioia S, Facciolo J, Riggio O, Radula L. Hepatic encephalopathy–recent advances in treatment and diagnosis. Expert Review of Gastroenterology & Hepatology. 2023 Mar;17(3):225-35. Doi: 10.1080/17474124.2023.2183386
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Pakistan Journal of Medicine and Dentistry
This work is licensed under a Creative Commons Attribution 4.0 International License.
This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY) 4.0 https://creativecommons.org/licenses/by/4.0/
